APA (7th ed.) Citation

Lanna, C., Rivieccio, A., Cattani, C., Artosi, F., Bianchi, L., & Campione, E. (2025). Tildrakizumab 200 mg: A step forward in psoriasis treatment with added metabolic benefits. Journal of Dermatological Treatment, 36(1), 1. https://doi.org/10.1080/09546634.2025.2512159

Chicago Style (17th ed.) Citation

Lanna, Caterina, Antonia Rivieccio, Chiara Cattani, Fabio Artosi, Luca Bianchi, and Elena Campione. "Tildrakizumab 200 Mg: A Step Forward in Psoriasis Treatment with Added Metabolic Benefits." Journal of Dermatological Treatment 36, no. 1 (2025): 1. https://doi.org/10.1080/09546634.2025.2512159.

MLA (9th ed.) Citation

Lanna, Caterina, et al. "Tildrakizumab 200 Mg: A Step Forward in Psoriasis Treatment with Added Metabolic Benefits." Journal of Dermatological Treatment, vol. 36, no. 1, 2025, p. 1, https://doi.org/10.1080/09546634.2025.2512159.